E34.322 — Insulin-like growth factor-1 (IGF-1) resistance
Is E34.322 billable?
Yes — E34.322 is billable for FY2027. E34.322 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. E34.322 may be submitted for encounters from October 1, 2026 through September 30, 2027.
E34.322 at a glance
| Code | E34.322 |
|---|---|
| Description | Insulin-like growth factor-1 (IGF-1) resistance |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does E34.322 group to?
E34.322 sits in MDC 10 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 643Endocrine Disorders with MCCmedical
- 644Endocrine Disorders with CCmedical
- 645Endocrine Disorders without CC/MCCmedical
How is E34.322 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to E34.322. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Short, shortening, shortness › statureNEC › due to › genetic causes › genetic syndrome with resistance to insulin-like growth factor-1
- Short, shortening, shortness › statureNEC › due to › genetic causes › insulin-like growth factor-1 receptordefect
- Short, shortening, shortness › statureNEC › due to › genetic causes › insulin-like growth factor-1resistance
- Short, shortening, shortness › statureNEC › due to › genetic causes › post-insulin-like growth factor-1 receptor signaling defect
Inclusion terms
Alternative wording in documentation that is classified to E34.322.
- Genetic syndrome with resistance to insulin-like growth factor-1
- Insulin-like growth factor-1 receptor (IGF-1R) defect
- Post-insulin-like growth factor-1 receptor signaling defect
Excludes1 — never code together — inherited from Chapter 4
The conditions below can never be reported together with E34.322 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Excludes1 — never code together — inherited from E20-E35
The conditions below can never be reported together with E34.322 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
Excludes1 — never code together — inherited from E34
The conditions below can never be reported together with E34.322 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- pseudohypoparathyroidism (E20.1)
Excludes1 — never code together — inherited from E34.3
The conditions below can never be reported together with E34.322 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- achondroplastic short stature (Q77.4)
- hypochondroplastic short stature (Q77.4)
- nutritional short stature (E45)
- pituitary short stature (E23.0)
- progeria (E34.8)
- renal short stature (N25.0)
- Russell-Silver syndrome (Q87.19)
- short-limbed stature with immunodeficiency (D82.2)
- short stature (child) (R62.52)
- short stature in specific dysmorphic syndromes - code to syndrome - see Alphabetical Index
- short stature NOS (R62.52)
How long has E34.322 existed?
E34.322 first appears in FY2023.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.